Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple Helicobacter pylori eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers.
Takeuchi T, Umegaki E, Takeuchi N, Yoda Y, Kojima Y, Tokioka S, Higuchi K; OMC G&H research group. Takeuchi T, et al. Among authors: kojima y. J Clin Biochem Nutr. 2012 Nov;51(3):189-95. doi: 10.3164/jcbn.12-15. Epub 2012 Jun 8. J Clin Biochem Nutr. 2012. PMID: 23170046 Free PMC article.
Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
Kuramoto T, Umegaki E, Nouda S, Narabayashi K, Kojima Y, Yoda Y, Ishida K, Kawakami K, Abe Y, Takeuchi T, Inoue T, Murano M, Tokioka S, Higuchi K. Kuramoto T, et al. Among authors: kojima y. BMC Gastroenterol. 2013 May 14;13:85. doi: 10.1186/1471-230X-13-85. BMC Gastroenterol. 2013. PMID: 23672202 Free PMC article. Clinical Trial.
Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
Umegaki E, Kuramoto T, Kojima Y, Nouda S, Ishida K, Takeuchi T, Inoue T, Tokioka S, Higuchi K. Umegaki E, et al. Among authors: kojima y. Intern Med. 2014;53(4):283-90. doi: 10.2169/internalmedicine.53.1572. Intern Med. 2014. PMID: 24531083 Free article. Clinical Trial.
Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T, Oota K, Harada S, Edogawa S, Kojima Y, Sanomura M, Sakaguchi M, Hayashi K, Hongoh Y, Itabashi T, Kitae H, Hoshimoto M, Takeuchi N, Higuchi K. Takeuchi T, et al. Among authors: kojima y. Intern Med. 2015;54(2):97-105. doi: 10.2169/internalmedicine.54.3412. Epub 2015 Jan 15. Intern Med. 2015. PMID: 25742999 Free article. Clinical Trial.
2,191 results